Advertisement

Topics

Companies Related to "Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom" [Most Relevant Company Matches] - Page: 4 RSS

11:36 EST 21st November 2018 | BioPortfolio

Here are the most relevant search results for "Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom" found in our extensive corporate database of over 50,000 company records.

Showing "Post Authorization Safety Study Biologicals Pandemic Influenza Vaccine" Companies 76–100 of 2,600+

Relevant

BIOCON, INC.

Since 1978 BIOCON has provided highly reliable, custom small animal research services to the region’s leading biomedical scientists. Whether your study involves small animal housing, breeding and colony management, research study applications, safety testing, custom antibody production or fully-compliant Good Laboratory Practices, BIOCON implements our client’s research initiative with dedicat...


Novavax, Inc.

Novavax, Inc. is a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The company produces potent VLP-based recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create co...

Bio-India Biologicals (BIB) Corporation

Bio-India Biologicals (BIB) Corporation technology driven organisation involved in production and development of natural based ingredients and active principles for Pharmaceutical, Nutraceutical, Health Industry, Homeopathic, natural medicine and also herbal industries. Please find below our specialized product range:- - Plant Extracts - Pure Botanicals - Natural Co...


Ansun BioPharma

Ansun BioPharma is a clinical stage biopharmaceutical company focused on the development of unique host-directed anti-viral therapies for respiratory viruses. Ansun BioPharma has two products in late stage clinical development. FluDaseTM is a first-in-class broad-spectrum investigational therapeutic agent to treat all forms of influenza, including pandemic...

Novartis Vaccines and Diagnostics

Novartis Vaccines is a global leader in providing vaccines to protect against deadly meningococcal disease. Through industry-leading scientific expertise, the company is focused on extending critical meningococcal vaccines research. In addition to developing Menveo vaccine, Novartis Vaccines is developing a recombinant vaccine for its potential to provide broad coverage against multiple strains of...

Vaccine and Infectious Disease Organization

VIDO is a world leader in the research and development of vaccine and immunotherapeutic technologies for livestock and humans. It is credited with five "world firsts" in animal vaccine research, and is expanding into human health applications. Current research interests include vaccines against a number of food-borne organisms, and novel vaccine delivery systems including needle-free methods. VIDO...

Hunter Immunology Limited

Our lead product is a vaccine currently called HI-164OV. It works by controlling bacterial colonisation of airways damaged by inhaled toxins. It has been developed to treat patients with Chronic Obstructive Pulmonary Disease (COPD) which includes bronchitis and emphysema. HI-164OV could help improve the lives of over one million Australians with COPD, and contribute towards saving Australia ...

Aus Bio Ltd.

Aus Bio Ltd. is a public but unlisted, Melbourne based biotechnology research and development company. It develops innovative research program to create new therapeutic products for specific disease states. Aus Bio is uniquely placed to develop the next generation therapeutics to combat influenza as Aus Bio’s senior scientists were closely involved, w...

Abt Associates Clinical Trials

Abt Associates Clinical Trials (AACT) is a full-service Contract Research Organization dedicated to serving the pharmaceutical, biotechnology, and medical device industries. AACT works with our clients to determine the safety and efficacy of their drugs, biologics, and devices supporting the process of obtaining FDA and other regulatory approvals. In the pre-approval phases, we offer our clients a...

SBL VACCIN AB

SBL Vaccines (SBL) is a Swedish registered company with in-house research, development and manufacturing capabilities, marketing our specialist vaccines internationally. A complete vaccine portfolio sourced from global vaccine companies is marketed in the Nordic region by our distribution division based in Stockholm.Our core product Dukoral is an oral vaccine that protects against cholera and trav...

Post-n-Track

Post-n-Track is an information logistics provider for healthcare management, enabling payers, providers, health systems and vendors to securely manage, control and optimize the flow of health information. Post-n-Track aligns the business value of information with the appropriate expertise, infrastructure, communication channels, transaction standards, busi...

Post & Schell

Post & Schell, established in 1968, currently has approximately 165 lawyers in seven offices: Allentown, Harrisburg, Lancaster, Philadelphia, Pittsburgh, Pa., Princeton, N.J. and Washington, D.C. The law firm provides litigation, corporate, transactional, regulatory, compliance, consulting and educational services locally, regionally and nationally t...

Exalpha Biologicals, Inc

Nil

Affinivax Inc.

Affinivax is advancing a next generation conjugate vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging infectious diseases. Backed by an investment from the Bill & Melinda Gates Foundation and working with world experts in vaccine discovery and development, Affinivax is focused ...

Progenics Pharmaceuticals

Progenics Pharmaceuticals, Inc., of Tarrytown, NY, is a biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Principal programs are directed toward gastroenterology as well as the treatment of HIV infection and cancer. The Company has fo...

Avant Immunotherapeutics

AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. The company is developing a broad portfolio of vaccines against viral and bacterial diseases, including single-dose oral vaccines aimed a protecting travelers from cholera, typhoid fever and other illnesses. In addition, the co...

Emergent BioSolutions

Emergent BioSolutions Inc. is a biopharmaceutical company dedicated to one simple mission—to protect life. We develop, manufacture and commercialize immunobiotics, consisting of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Our biodefense business focuses on immunobiotics for use against biological agents that are potential weapons of bioterroris...

sterna biologicals GmbH & Co. KG

AFFiRiS AG

On the basis of the company's own patents, AFFiRiS develops tailor-made peptide vaccines against Alzheimer's disease, atherosclerosis, Parkinson's disease hypertension and four other conditions with an urgent medical requirement and attractive market volumes. Alzheimer's is currently the most advanced project, with two potential products having just completed the phase I clinical studies. In O...

IAVI

The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. Founded in 1996, IAVI works with partners in 25 countries to research, design and develop AIDS vaccine candidates. In addition, IAVI conduct...

Filligent

In 2008, Filligent developed a revolutionary technology, called BioFriend(TM), which kills viruses and bacteria on contact. BioFriend's molecular technology can be applied to substrates such as rayon and cotton textile fiber. BioFriend(TM) captures pathogens by mimicking the sites on human cells to which they normally attach, then, destroys them by disrupting their surfaces (viruses) and cell ...

Vista Biologicals Corporation

Vista Biologicals specializes in providing contract production of animal cells, cell-derived products, and related contract research to the chemical, pharmaceutical, and biotechnology industries.

GlycoMimetics, Inc. and International AIDS Vaccine Initiative and Glycosensors and Diagnostics, LLC

IAVI is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. Founded in 1996, IAVI works with partners in 25 countries to research, design and develop AIDS vaccine candidates. In addition, IAVI conducts policy analyses and serves as an advocate for ...

Post Capital Partners LLC

Post Capital Partners (www.postcp.com) is a private investment firm that makes both minority growth and control investments in companies with a minimum of $10 million of revenue and $2 million of EBITDA. Post Capital primarily employs an “Executive-First” deal sourcing and investment strategy in which they pursue growth capital investments, manag...

Redbiotec

Redbiotec is a privately held Swiss biopharmaceutical company founded in 2006 and based in Zurich-Schlieren. The company uses its proprietary rePAX® co-expression technology for the efficient generation of multi-component virus-like particles (VLPs) and other protein assemblies. The company entered the field of VLP vaccines in 2008 and currently has ...


More From BioPortfolio on "Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks